Deep Brain Stimulation Clinical Trials

Clinical trials related to Deep Brain Stimulation Procedure

Deep Brain Stimulation for Disorders of Addiction: Mechanisms and a Pilot Blinded Randomized Cross-over Placebo Controlled Trial

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study is testing whether deep brain stimulation (DBS) can safely help people with severe alcohol use disorder who have not improved with standard treatments. DBS uses small electrical signals to change activity in brain areas linked to craving, self-control, and emotion. The study will test whether this treatment can reduce how often people drink and how much they drink each day. Researchers will also record brain activity to better understand how DBS affects craving and relapse.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 60
Healthy Volunteers: f
View:

• Adults aged 18 to 60 years

• Diagnosed with Alcohol Use Disorder (AUD) according to DSM-5 criteria

• Primary diagnosis of treatment-refractory AUD (comorbid nicotine dependence, other psychoactive substance use disorders, moderate major depressive disorder, anxiety disorders or obsessive-compulsive disorder are permissible if AUD is principal)

• Disorder duration of AUD ≥ 5 years

• At least 3 unsuccessful attempts at achieving abstinence

• Failed prior psychotherapy and standard pharmacotherapy for AUD

• Medically and neurologically suitable for surgery and MRI-compatible

• Capable of providing informed consent and willing to comply with study procedures

Locations
Other Locations
United Kingdom
Cambridge University Hospitals (Addenbrooke's Hospital)
RECRUITING
Cambridge
King's College Hospital
RECRUITING
London
Time Frame
Start Date: 2025-07-01
Estimated Completion Date: 2027-10-31
Participants
Target number of participants: 9
Treatments
Experimental: Dual Stimulation (Nucleus Accumbens + Ventral Internal Capsule)
Participants receive active deep brain stimulation simultaneously targeting both the nucleus accumbens and the ventral internal capsule.
Active_comparator: Single Stimulation - Nucleus Accumbens Only
Participants receive active deep brain stimulation targeting the nucleus accumbens only, with ventral internal capsule stimulation inactive.
Active_comparator: Single Stimulation - Ventral Internal Capsule Only
Participants receive active deep brain stimulation targeting the ventral internal capsule only, with nucleus accumbens stimulation inactive.
Sham_comparator: Sham Stimulation (Inactive)
Participants receive sham (inactive) deep brain stimulation. The implanted device is turned off; no therapeutic stimulation is provided.
Related Therapeutic Areas
Sponsors
Collaborators: King's College Hospital NHS Trust, Cambridge University Hospitals NHS Foundation Trust
Leads: University of Cambridge

This content was sourced from clinicaltrials.gov